JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Начало・Списък с акции・Pulse Biosciences Inc

Pulse Biosciences Inc

Затворен

СекторЗдравеопазване

13.83 2.52

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

13.59

Максимум

13.93

Ключови измерители
By Trading Economics
Приходи	-217K -19M
Продажби	86K 86K
EPS	-0.29
Марж на печалбата	-22,540.698
Служители	75
EBITDA	-228K -19M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+61.53% upside

Дивиденти
By Dow Jones
Следващи печалби	26.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-179M 958M
Предишно отваряне	11.31
Предишно затваряне	13.83

Настроения в новините

By Acuity

34%

66%

94 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

16.59 / 17.17 Подкрепа & съпротива

Pulse Biosciences Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.01.2026 г., 20:14 ч. UTC

Придобивния, сливания и поглъщания

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30.01.2026 г., 23:47 ч. UTC

Придобивния, сливания и поглъщания

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30.01.2026 г., 23:41 ч. UTC

Пазарно говорене

Deckers Outdoor Seen as Undervalued -- Market Talk

30.01.2026 г., 23:12 ч. UTC

Придобивния, сливания и поглъщания

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30.01.2026 г., 22:20 ч. UTC

Печалби

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30.01.2026 г., 22:10 ч. UTC

Пазарно говорене

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

30.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

30.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

30.01.2026 г., 21:42 ч. UTC

Печалби

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30.01.2026 г., 21:36 ч. UTC

Печалби

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30.01.2026 г., 21:33 ч. UTC

Печалби

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30.01.2026 г., 20:42 ч. UTC

Печалби

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30.01.2026 г., 20:37 ч. UTC

Придобивния, сливания и поглъщания

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30.01.2026 г., 20:20 ч. UTC

Пазарно говорене

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30.01.2026 г., 20:13 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30.01.2026 г., 19:52 ч. UTC

Печалби

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30.01.2026 г., 19:29 ч. UTC

Пазарно говорене

Печалби

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30.01.2026 г., 19:09 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

30.01.2026 г., 19:09 ч. UTC

Пазарно говорене

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30.01.2026 г., 19:07 ч. UTC

Пазарно говорене

Canada Performing Well Below Economic Potential -- Market Talk

30.01.2026 г., 18:46 ч. UTC

Печалби

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30.01.2026 г., 18:34 ч. UTC

Печалби

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Сравнение с други в отрасъла

Ценова промяна

Pulse Biosciences Inc Прогноза

Ценова цел

By TipRanks

61.53% нагоре

12-месечна прогноза

Среден 22 USD 61.53%

Висок 22 USD

Нисък 22 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Pulse Biosciences Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Pulse Biosciences Inc през последните 3 месеца.

Техническа оценка

By Trading Central

16.59 / 17.17Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Настроение

By Acuity

94 / 352 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.